Abstract
Crack cocaine is the crystal form of cocaine, produced by adding sodium bicarbonate to cocaine base paste. Brazil is the largest consumer of crack cocaine in the world. Users of crack cocaine show important physiological and behavioral alterations, including neuropsychiatric symptoms, such as anxiety-related symptoms. Nevertheless, few pre-clinical studies have been previously performed to understand the neurobiological effects of crack cocaine. The purpose of the present study was to investigate effects of the subchronic treatment (5 days, IP) of rats with crack cocaine in an animal model of anxiety/panic, the elevated T-maze (ETM). The ETM model allows the measurement of two behavioral defensive responses, avoidance and escape, in clinical terms, respectively, associated to generalized anxiety and panic disorder, the two main psychiatric conditions that accompany substance use disorders. Immediately after the ETM model, animals were tested in an open field for locomotor activity assessment. Analysis of delta FosB protein immunoreactivity was used to map areas activated by crack cocaine exposure. Results showed that crack treatment selectively altered escape displayed by rats in the ETM test, inducing either a panicolytic (18 mg/kg IP) or a panicogenic-like effect (25 and 36 mg/kg IP). These effects were followed by the altered functioning of panic-modulating brain regions, i.e., the periaqueductal gray and the dorsal region and lateral wings of the dorsal raphe nucleus. Treatment with 36 mg/kg of crack cocaine also increased locomotor activity. These are the first observations performed with crack cocaine in a rodent model of anxiety/panic and contribute to a better understanding of the behavioral and neurobiological effects of crack cocaine.
Similar content being viewed by others
References
Ali H, Bushra R, Aslam N (2011) Profile of drug users in Karachi City, Pakistan. E Mediterr Health J 17:41–45. https://doi.org/10.26719/2011.17.1.41
Allain F, Minogianis E-A, Roberts DCS, Samaha A-N (2015) How fast and how often: the pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev 56:166–179. https://doi.org/10.1016/j.neubiorev.2015.06.012
Amano K, Tanikawa T, Iseki H, Kawabatake H, Notani M, Kawamura H, Kitamura K (1978) Single neuron analysis of the human midbrain tegmentum. Rostral mesencephalic reticulotomy for pain relief. Appl Neurophysiol 41:66–78. https://doi.org/10.1159/000102402
Areal LB, Rodrigues LCM, Andrich F, Moraes LS, Cicilini MA, Mendonça JB, Pelição FS, Nakamura-Palacios EM, Martins-Silva C, Pires RGW (2015) Behavioral, biochemical and molecular changes induced by chronic crack-cocaine inhalation in mice: the role of dopaminergic and endocannabinoid systems in the prefrontal cortex. Behav Brain Res 290:8–16. https://doi.org/10.1016/j.bbr.2015.04.036
Bandler R, Shipley MT (1994) Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trend Neurosci 17:379–389. https://doi.org/10.1016/0166-2236(94)90047-7
Blanchard DC, Blanchard RJ (1999) Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23:981–991. https://doi.org/10.1016/S0149-7634(99)00031-7
Blanchard DC, Griebel G, Blanchard RJ (2001) Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25:205–218. https://doi.org/10.1016/S0149-7634(01)00009-4
Bolla KI, Cadet JL, London ED (1998) The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci 10:280–289. https://doi.org/10.1176/jnp.10.3.280
Brandão ML, Aguiar JC, Graeff FG (1982) GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 16:397–402. https://doi.org/10.1016/0091-3057(82)90441-5
Brandão ML, Viana DM, Masson S (2003) Neural organization of different types of fear: implications for the understanding of anxiety. Braz J Psychiatry 25:36–41. https://doi.org/10.1590/S1516-44462003000600009
Bueno CH Jr, Zangrossi H, Nogueira RL, Soares VP, Viana MB (2005) Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal gray of rats. Eur J Pharmacol 516:239–346. https://doi.org/10.1016/j.ejphar.2005.04.045
Butler AJ, Rehm J, Fischer B (2017) Health outcomes associated with crack-cocaine use: systematic review and meta-analyses. Drug Alcohol Depend 180:401–416. https://doi.org/10.1016/j.drugalcdep.2017.08.036
Campos AC, Fogaça MV, Aguiar DC, Guimarães FS (2013) Animal models of anxiety disorders and stress. Braz J Psychiatry 35(Suppl 2):S101–S111. https://doi.org/10.1590/1516-4446-2013-1139
Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlate, disability, and comorbidity of DSM-IV drug abuse and dependence in the united states: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566–576. https://doi.org/10.1001/archpsyc.64.5.566
Erhardt E, Zibetti LCE, Godinho JM, Bacchieri B, Barros HMT (2006) Behavioral changes induced by cocaine in mice are modified by a hyperlipidic diet or recombinant leptin. Braz J Med Biol Res 39:1625–1635. https://doi.org/10.1590/S0100-879X2006001200014
Falck RS, Wang J, Carlson RG (2008) Among long-term crack smokers, who avoids and who succumbs to cocaine addiction? Drug Alcohol Depend 98:24–29. https://doi.org/10.1016/j.drugalcdep.2008.04.004
Fernandez-de-Molina A, Hunsperger RW (1959) Central representation of affective reactions in forebrain and brain stem: electrical stimulation of amygdala, stria terminalis, and adjacent structures. J Physiol 145:251–265. https://doi.org/10.1113/jphysiol.1959.sp006140
Garcia RCT, Torres LH, Balestrin NT, Andrioli TC, Flório JC, Oliveira CDR, Costa JL, Yonamine M, Sandoval MRL, Camarini R, Marcourakis T (2017) Anhydroecgonine methyl ester, a cocaine pyrolysis product, may contribute to cocaine behavioral sensitization. Toxicology 376:44–50. https://doi.org/10.1016/j.tox.2016.04.009
Gawin FH (1988) Chronic neuropharmacology of cocaine: progress in pharmacotherapy. J Clin Psychiatry 49:11–16
Gawin FH (1989) Cocaine abuse and addiction. J Fam Pract 29:193–197
Graeff FG (2004) Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28:239–259. https://doi.org/10.1016/j.neubiorev.2003.12.004
Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23(2):237–246. https://doi.org/10.1016/S0149-7634(98)00024-4
Graeff FG (2012) New perspective on the pathophysiology of panic: merging serotonin and opioids in the periaqueductal gray. Braz J Med Biol Res 45:366–375. https://doi.org/10.1590/S0100-879X2012007500036
Graeff FG Jr, Zangrossi H (2002) Animal models of anxiety. In: D’Haenen H, Den Boer JA, Willner P (eds) Biological psychiatry. Wiley, London, pp 879–893
Gray JA, McNaughton N (2000) The Neuropsychology of Anxiety: an enquiry into the functions of the septo-hippocampal system. In: Oxford Psychology Series, Oxford University Press, USA 141:634. https://doi.org/10.1017/S000712500011373X
Gulley JM, Hoover BR, Larson GA, Zahniser NR (2003) Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter. Neuropsychopharmacol 28:2089–2101. https://doi.org/10.1038/sj.npp.1300279
Hale MW, Shekhar A, Lowry CA (2012) Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol 32:695–708. https://doi.org/10.1007/s10571-012-9827-1
Hsu SM, Raine L (1881) Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29:1349–1353. https://doi.org/10.1177/29.11.6172466
Hsu SM, Raine L, Fanger H (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816–821. https://doi.org/10.1093/ajcp/75.6.816
Huang KW, Ochandarena NE, Philson AC, Hyun M, Birnbaum JE, Cicconet M, Sabatini BL (2019) Molecular and anatomical organization of the dorsal raphe nucleus. Elife 14:e46464. https://doi.org/10.7554/eLife.46464
Hyman SE (2001) A 28-year-old man addicted to cocaine. JAMA 286:2586–2594. https://doi.org/10.1001/jama.286.20.2586
Johnson PL, Hollis JH, Moratalla R, Lightman SL, Lowry CA (2005) Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J Psychopharmacol 19:327–341. https://doi.org/10.1177/0269881105053281
Johnson KW, Shamblen SR, Courser MW, Young L, Abadi MH, Browne T (2013) Drug use and treatment success among gang and non-gang members in El Salvador: a prospective cohort study. Subst Abuse Treat Prev Policy 8:20. https://doi.org/10.1186/1747-597X-8-20
Kalivas PW, McFarland K (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacol 168:44–56. https://doi.org/10.1007/s00213-003-1393-2
Kohtz AS, Paris JJ, Frye CA (2010) Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progesterone levels among intact rats. Horm Behav 57:474–480. https://doi.org/10.1016/j.yhbeh.2010.02.005
Lacayo A (1995) Mirthless laughter in a case of Creutzfeldt-Jakob disease. J Neuropsychiatry Clin Neurosci 7:386–387. https://doi.org/10.1176/jnp.7.3.386
Lankenau SE, Clatts MC, Goldsamt LA, Welle DL (2004) Crack cocaine injection practices and HIV risk: findings from New York and Bridgeport. J Drug Issues 34:319–332. https://doi.org/10.1177/002204260403400204
Laranjeira R, Mitsuhiro SS (2012) Addiction research centres and the nurturing of creativity. National Institute on Alcohol and Drugs Policies, Brazil. Addiction 107:727–732. https://doi.org/10.1111/j.1360-0443.2011.03387.x
Lipaus IFS, Gomes EF, Martins CW, Silva CME, Pires RGW, Malgarin F, Scuck PF, Nakamura-Palacios EM, Rodrigues LCM (2019) Impairment of spatial working memory and oxidative stress induced by repeated crack cocaine inhalation in rats. Behav Brain Res 359:910–917. https://doi.org/10.1016/j.bbr.2018.06.020
Lurie IS, Moore JM, Kram TC, Cooper DA (1990) Isolation, identification and separation of isomeric truxillines in illicit cocaine. J Chromatogr A 504:391–401. https://doi.org/10.1016/S0021-9673(01)89542-X
Maranhão LA, Fontes MK, Kamimura ASS, Nobre CR, Moreno BB, Pusceddu FH, Cortez FS, Lebre DT, Marques JR, Abessa DMS, Ribeiro DA, Pereira CDS (2017) Exposure to crack cocaine causes adverse effects on marine mussels Perna perna. Mar Pollut Bull 123:410–414. https://doi.org/10.1016/j.marpolbul.2017.08.043
Moretti EG, Yujra VQ, Claudio SR, Silva MJ, Vilegas W, Pereira CDS, Oliveira F, Ribeiro DA (2016) Acute crack cocaine exposure induces genetic damage in multiple organs of rats. Environ Sci Pollut Res Int 23:8104–8112. https://doi.org/10.1007/s11356-016-6141-3
Nankova BB, Rivkin M, Kelz M, Nestler EJ, Sabban EL (2000) Fos-related Antigen 2: Potential mediator of the transcriptional activation in rat adrenal medulla evoked by repeated immobilization stress. J Neurosci 20:5647–5653. https://doi.org/10.1523/JNEUROSCI.20-15-05647.2000
Nashold BS, Wilson WP, Slaughter DG (1969) Sensations evoked by stimulation in the midbrain of man. J Neurosurg 30:14–24. https://doi.org/10.3171/jns.1969.30.1.0014
Nestler EJ (2005) Neurobiology of cocaine addiction. Sci Pract Perspect 3:4–10. https://doi.org/10.1151/spp05314
Nestler EJ (2008) Transcriptional mechanisms of addiction: role of delta FosB. Philos Trans R Soc Lond B Biol Sci 363:3245–3255. https://doi.org/10.1098/rstb.2008.0067
Nestler EJ (2012) Transcriptional mechanisms of drug addiction. Clin Psychopharmacol Neurosci 10:136–143. https://doi.org/10.9758/cpn.2012.10.3.136
Nogueira RL, Graeff FG (1991) 5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal gray. Behav Pharmacol 2:73–77. https://doi.org/10.1097/00008877-199102000-00010
Nutt DJ, King LA, Phillips LD (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376:1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
Paine TA, Jackman SL, Olmstead MC (2002) Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 13:511–523. https://doi.org/10.1097/00008877-200211000-00001
Paul ED, Lowry CA (2013) Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J Psychopharmacol 27:1090–1106. https://doi.org/10.1177/0269881113490328
Paxinos G, Watson C (2008) The rat brain in stereotaxic coordinates, compact, 6th edn. Academic Press, Sidney
Pereira CDS, Maranhão LA, Cortez FS, Pusceddu FH, Santos AR, Ribeiro DA, Cesar A, Guimarães LL (2016) Occurrence of pharmaceuticals and cocaine in a Brazilian costal zone. Sci Total Environ 548–549:148–154. https://doi.org/10.1016/j.scitotenv.2016.01.051
Perrotti LI, Weaver RR, Robison B, Renthal W, Maze I, Yazdani S, Elmore RG, Knapp DJ, Selley DE, Martin B, Sim-Selley L, Bachtell RK, Self DW, Nestler EJ (2008) Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 62:358–369. https://doi.org/10.1002/syn.20500
Pires CM, Cavaco AM (2014) Communication between health professionals and patients: review of studies using the RIAS (Roter Interaction Analysis System) Method. Rev Assoc Med Bras 60:156–172. https://doi.org/10.1590/1806-9282.60.02.014
Plowman T, Rivier L (1983) Cocaine and cinnamoylcocaine content of Erythroxylum species. Ann Bot 51(5):641–659. https://doi.org/10.1093/oxfordjournals.aob.a086511
Poltronieri SC Jr, Zangrossi H, Viana MB (2003) Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 147:185–192. https://doi.org/10.1016/S0166-4328(03)00151-7
Ribeiro M, Trevizol AP, Frajzinger R, Robeiro A, Speierl H, Pires L, Andraus M, Tsanaclis L, Alonso ALS, Cordeiro Q, Laranjeira R (2019) Adulterants in crack cocaine in Brazil. Trends Psychiatry Psychother 41:186–190. https://doi.org/10.1590/2237-6089-2017-0143
Riezzo I, Fiore C, Carlo DD, Pascale N, Neri M, Turillazzi E, Fineschi V (2012) Side effects of cocaine abuse: multiorgan toxicity and pathological consequences current. Med Chem 19:5624–5646. https://doi.org/10.2174/092986712803988893
Roelofs K (2017) Freeze for action: neurobiological mechanisms in animal and human freezing. Philos Trans R Soc Lond B Biol Sci 372(1718):20160206. https://doi.org/10.1098/rstb.2016.0206
Rogerio R, Takahashi RN (1992) Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol Biochem Behav 43:631–633. https://doi.org/10.1016/0091-3057(92)90203-R
Rosário BA, Nazaré MFS, Estadella D, Ribeiro DA, Viana MB (2018) Behavioral and neurobiological alterations induced by chronic use of crack cocaine. Rev Neurosci 31:59–75. https://doi.org/10.1515/revneuro-2018-0118
Rosen MI, Kosten T (1992) Cocaine-associated panic attacks in methadone-maintained patients. Am J Drug Alcohol Abuse 18:57–62. https://doi.org/10.3109/00952999209001611
Sela VR, Biesdorf C, Ramos DH Jr, Zangrossi H, Graeff FG, Audi EA (2011) Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze. Neurosci Lett 495:63–66. https://doi.org/10.1016/j.neulet.2011.03.040
Shanti RM, Khan J, Eliav E, Ziccardi VB (2013) Is there a role for a collagen conduit and anti-inflammatory agent in the management of partial peripheral nerve injuries. Int J Oral Maxillofac Surg 71:1119–1125. https://doi.org/10.1016/j.joms.2011.03.054
Shihomatsu HM, Martins EAJ, Cotrim MEB, Lebre DT, Ortiz N, Pires MAF (2017) Development and validation of methodology SPE-LC-MS/MS for pharmaceuticals and illicit drugs determination in Guarapiranga Reservoir Waters-São Paulo/SP, Brazil. J GEP 5:1–17. https://doi.org/10.11606/T.85.2015.tde-28042015-095207
Smith JP, Book SW (2010) Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addict Behav 35:42–45. https://doi.org/10.1016/j.addbeh.2009.07.002
Spiacci A Jr, Coimbra NC Jr, Zangrossi H (2012) Differential involvement of dorsal raphe subnuclei in the regulation of anxiety-and-panic-related defensive behaviors. Neurosci 227:350–360. https://doi.org/10.1016/j.neuroscience.2012.09.061
Stansley BJ, Yamamoto BK (2014) Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus. J Pharmacol Exp Ther 351:440–447. https://doi.org/10.1124/jpet.114.218966
Takahashi RN, Rogerio R (1991) Nifedipine interacts with cocaine in the elevated plus-maze in rats. Res Comm Subst Abuse 12:19–26
Teixeira RC Jr, Zangrossi H, Graeff FG (2000) Behavioral effects of acute and chronic imipramine in the elevated T maze model of anxiety. Pharmacol Biochem Behav 65:571–576. https://doi.org/10.1016/S0091-3057(99)00261-0
Thomsen M, Caine SB (2011) Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Exp Clin Psychopharmacol 19:321–341. https://doi.org/10.1037/a0024798
United Nations Office on Drugs and Crime (UNODOC) (2014) World Drug Report 2014, Vienna, Austria
Vaughn MG, Fu Q, Perron BE, Bohnert ASB, Howard MO (2010) Is crack cocaine use associated with greater violence than powdered cocaine use? Results from a national sample. Am J Drug Alcohol Abuse 36:181–186. https://doi.org/10.3109/00952990.2010.491877
Viana MB, Tomaz CA, Graeff FG (1994) The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49:549–554. https://doi.org/10.1016/0091-3057(94)90067-1
Waters RP, See RE (2011) Chronic cocaine self-administration attenuates the anxiogenic-like and stress potentiating effects of the benzodiazepine inverse agonist FG 7142. Pharmacol Biochem Behav 99:408–413. https://doi.org/10.1016/j.pbb.2011.05.021
Wscieklica T, Silva MSCF, Lemes JA, Melo-Thomas L, Céspedes IC, Viana MB (2017) Deep brain stimulation of the dorsal raphe inhibits avoidance and escape reactions and activates forebrain regions related to the modulation of anxiety/panic. Behav Brain Res 321:193–200. https://doi.org/10.1016/j.bbr.2016.11.054
Yang XM, Gorman AL, Dunn AJ, Goeders NE (1992) Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol Biochem Behav 41:643–650. https://doi.org/10.1016/0091-3057(92)90386-T
Yoshida M, Shirouzu M, Tanaka M, Semba K, Fibiger HC (1989) Dopaminergic neurons in the nucleus raphe dorsalis innervate the prefrontal cortex in the rat: a combined retrograde tracing and immunohistochemical study using anti-dopamine serum. Brain Res 496:373–376. https://doi.org/10.1016/0006-8993(89)91091-3
Young SL, Vosper HJ, Phillips SA (1992) Cocaine: its effects on maternal and child health. Pharmacotherapy 12:2–17. https://doi.org/10.1002/j.1875-9114.1992.tb02664.x
Zubaran C, Foresti K, Thorell MR, Franceschini P, Homero W (2010) Depressive symptoms in crack and inhalant users in southern Brazil. J Ethn Subst Abuse 9:221–236. https://doi.org/10.1080/15332640.2010.501626
Zubaran C, Foresti K, Thorell MR, Franceschini PR (2013) Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil. Rev Assoc Med Bras 59:360–367. https://doi.org/10.1016/j.ramb.2013.01.008
Acknowledgements
This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil. Bárbara dos Anjos Rosário was the recipient of a fellowship grant from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES; grant 001), Brazil. Maria de Fátima Santana Nazaré was the recipient of a fellowship grant from FAPESP, Brazil.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Bill J Yates.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
dos Anjos Rosário, B., de Fátima Santana de Nazaré, M., Lemes, J.A. et al. Repeated crack cocaine administration alters panic-related responses and delta FosB immunoreactivity in panic-modulating brain regions. Exp Brain Res 239, 1179–1191 (2021). https://doi.org/10.1007/s00221-020-06031-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-020-06031-2